高级搜索

具有神经内分泌分化食管癌并发糖尿病的临床研究

Clinical Analysis of Esophageal Carcinoma with Neuroendocrine Differentiation Complicated Diabetes Mellitus

  • 摘要: 目的 探讨具有神经内分泌分化食管癌并糖尿病患者的治疗和预后。方法 从1992年1月~1997年10月共收治食管癌并糖尿病患者20例,通过内窥镜活检、免疫组织化学和空腹血糖检测确诊。其中小细胞未分化癌6例,低分化鳞癌8例,中分化鳞癌5例,高分化鳞癌1例。全部病人接受化学治疗和放射治疗。结果 随访6月~3年,均有完整的随访资料,中位生存7.5月,1年生存率15%(3/20),2年生存率10%(2/20),3年生存率5%(1/20)。随着食管癌症状缓解,血糖基本恢复正常。结论 具有神经内分泌分化食管癌并糖尿病患者预后差,进一步治疗需深入研究。

     

    Abstract: Objective To evaluate the treatment and Prognosis of the Patients with esophageal Carcinoma with neuroendocrine differntion complicated diabetes mellitus. Methods From Jan.1992 to Cot.1997,20Cases of esophageal carcinoma complicated diabetes mellitus were treated.Diagnoses were to confirmed by endoscopy.biopsies,immunohistochemistry and glycermia test.They are small cell carcinoma (6 cases),Poorly,moderately and highly differentiated squmous cell carcinema (8cases, 5cases,1cases).All patients received chemotherapy and external radiation. Results The follow-up time ranged from 6to 36 months.The l-year、2-year and 3-year surivival rates was 15%、10% and 5%,respectively. Conclusion The Prognosis of esophageal carcinoma with neuroendocrine differention complicated diabetes is inferior to esophageal carcinoma without diabetes mellitus.Further study should be carried out.

     

/

返回文章
返回